GX 623 (Ziagen 300 mg)

Generic Name: abacavir

Pill imprint GX 623 has been identified as Ziagen 300 mg.

Ziagen is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Ziagen 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GX 623

Ziagen 300 mg GX 623
Ziagen 300 mg GX 623
Ziagen 300 mg GX 623
Ziagen
Generic Name:
abacavir
Imprint:
GX 623
Strength:
300 mg
Color:
Yellow
Size:
18.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
GlaxoSmithKline
National Drug Code (NDC):
00173-0661
Inactive Ingredients:
silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
hypromelloses
polysorbate 80
ferric oxide yellow
triacetin
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
49702-0221 ViiV Healthcare
54569-4883 A S Medication Solutions LLC (repackager)
54868-4522 Physicians Total Care Inc (repackager)
35356-0075 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)